Flarin Holdings

Pharmaceutical Manufacturing • London, England, United Kingdom • 1-10 Employees

Company overview

Headquarters	Central Point, 45 Beech Street, London, UK EC2Y 8AD, GB
Website	flarinholdings.com
NAICS	3254
Founded	2019
Employees	1-10

Key Contact at Flarin Holdings

Alan Armstrong

Director

About Flarin Holdings

Flarin Holdings Ltd owns infirst Ltd, which focuses exclusively on the rapid commercialisation and globalisation of Flarin® (patent protected lipid formulation of ibuprofen). Flarin® is the first and only OTC lipid formulated ibuprofen clinically proven to be as effective as prescription-strength ibuprofen – without a prescription1. It is indicated for a wide range of symptoms including relief of rheumatic pain or muscular pain, back pain and the pain of non-serious arthritic conditions caused by swelling, stiffness and inflammation.

Flarin Holdings revenue & valuation

Annual revenue	$256,665
Revenue per employee	$86,000
Estimated valuation?This valuation is estimated based on industry average for the Pharmaceutical Manufacturing industry and current estimated revenues	$821,328
Total funding	No funding

Employees by Management Level

Total employees: 1-10

Seniority

Employees

Director

Funding Data

Flarin Holdings has never raised funding before.

Frequently asked questions

Flarin Holdings is located in London, England, GB.

Flarin Holdings was founded in 2019, making it 7 years old. The company has established itself as a significant player in its industry over this time.

Flarin Holdings has approximately 1-10 employees. The company continues to grow its workforce to support its business operations and expansion.

Key Contact at Flarin Holdings

Alan Armstrong

Director

4.8

40,000 users